PAMU
ACOR

Pictet Asset Management (UK)’s Acorda Therapeutics ACOR Stock Holding History

Pictet Asset Management (UK)’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,998
Closed -$3.19M – 1050
2019
Q1 		$3.19M Buy
1,998
+673
+51% +$1.21M 0.01% 792
2018
Q4 		$2.48K Buy
1,325
+423
+47% +$920K 0.01% 810
2018
Q3 		$2.13M Sell
902
-102
-10% -$316K ﹤0.01% 887
2018
Q2 		$3.46M Sell
1,004
-112
-10% -$343K 0.01% 734
2018
Q1 		$3.17M Buy
1,116
+198
+22% +$593K 0.01% 743
2017
Q4 		$2.36M Sell
918
-110
-11% -$313K 0.01% 788
2017
Q3 		$2.92M Buy
1,028
+349
+51% +$919K 0.01% 733
2017
Q2 		$1.13M Hold
679
– – ﹤0.01% 817
2017
Q1 		$1.71M Sell
679
-540
-44% -$1.55M 0.01% 789
2016
Q4 		$2.75M Sell
1,219
-1,627
-57% -$3.87M 0.01% 694
2016
Q3 		$7.13M Buy
2,846
+1,976
+227% +$5.9M 0.03% 499
2016
Q2 		$2.97M Buy
870
+327
+60% +$1.06M 0.01% 678
2016
Q1 		$2.13M Buy
543
+21
+4% +$87.2K 0.01% 688
2015
Q4 		$2.68M Sell
522
-252
-33% -$1.1M 0.01% 681
2015
Q3 		$2.46M Sell
774
-454
-37% -$1.76M 0.01% 695
2015
Q2 		$5.07M Buy
1,228
+325
+36% +$1.26M 0.02% 584
2015
Q1 		$3.26M Buy
903
+93
+11% +$426K 0.01% 672
2014
Q4 		$3.97M Buy
810
+23
+3% +$98.7K 0.02% 636
2014
Q3 		$3.2M Sell
787
-371
-32% -$1.39M 0.02% 654
2014
Q2 		$4.69M Buy
1,158
+272
+31% +$1.11M 0.02% 563
2014
Q1 		$4.03M Buy
886
+48
+6% +$194K 0.02% 588
2013
Q4 		$2.94M Sell
838
-250
-23% -$975K 0.02% 656
2013
Q3 		$4.47M Sell
1,088
-543
-33% -$2.34M 0.03% 540
2013
Q2 		$6.46M Buy
+1,631
New +$6.72M 0.04% 422

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Pictet Asset Management (UK)'s ACOR Position: Q2 2019 in Review

Pictet Asset Management (UK) sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 1,998 shares — an estimated $3.19M sold.

Pictet Asset Management (UK) first reported a position in ACOR in Q2 2013 and held it in 24 quarters. The position peaked at $7.13M in Q3 2016. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Pictet Asset Management (UK) reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 1,998 Acorda Therapeutics shares in Q2 2019, an estimated $3.19M.
  • Pictet Asset Management (UK) first reported a position in Acorda Therapeutics in Q2 2013 and held it in 24 quarters.
  • Pictet Asset Management (UK)'s Acorda Therapeutics position peaked at $7.13M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.